Académique Documents
Professionnel Documents
Culture Documents
1. TITLE PAGE
Title should be clear and precise
Center alignment
Thesis title should assume an “inverted pyramid”
Bold font, NOT in all caps.
2. APPROVAL SHEET
Duly signed by the adviser after passing the oral defense
3. ACKNOWLEDGEMENT
Includes the names of individual(s) and institution(s) who provided assistance that
have lead to the realization of your thesis.
4. ABSTRACT
Consists of (1) background of the study, (2) objective of the study, (3)
methodology, (4) results and conclusion
Single-spaced with a maximum of 300 words
5. TABLE OF CONTENTS
Lists the different parts of the manuscript with the corresponding page number
8. CHAPTER 1 – INTRODUCTION
Includes
i. BACKGROUND OF THE STUDY
ii. STATEMENT OF THE PROBLEM
iii. SIGNIFICANCE OF THE STUDY
iv. SCOPE AND LIMITATIONS OF THE STUDY
v. DEFINITION OF TERMS
The manuscript must be printed in short bond paper (8½ in x 11 in) using the UST thesis
template and the following format:
FONT
o Times New Roman
FONT SIZE
o Size 14 – Main headings including chapter number and title
o Size 12 – text
o Free size – title of tables/ graphs/ figures and text of tables
MARGINS
o Top – 1.45
o Bottom – 1.25
o Left – 1.80
o Right – 0.93
SPACING
o Use DOUBLE SPACE for the text
3 double spaces BEFORE the chapter number
1 double space AFTER the chapter number
1. Full text must fit 8½ in. x 11 in. bond paper; maximum of 300 words.
2. Title – Times New Roman, bold, size 12
3. Authors’ name
a. Times New Roman, normal, size 10
b. Format: GIVEN NAME, M.I., SURNAME
c. Adviser(s) name(s) (without professional title) should be mentioned last.
4. Title and authors’ names are aligned center
5. Text - Times New Roman, normal, size 11, single-spaced, justified, no indentation
6. Scientific names must be in ITALICS, not underlined.
Sample abstract:
Krizia Carla E. Arzadon, Nicole Lynn Kimberly S. Chan, Ana Dominique A. Cuaresma, Kathleen Anne N. Lim,
Heidi Rose C. Tanjueco, Andrea Q. Carigma
Thrombocytopenia is a condition associated with a number of diseases and disorders in which there is an
abnormally low amount of platelets in the blood. Increasing the platelet count as supportive therapy can
prevent further complications brought about by thrombocytopenia. The present study examined the
decoction of Ipomoea batatas for its potential to increase the platelet count of Sprague-Dawley rats.
Leaves of Ipomoea batatas were collected and extracted using decoction method. This extract was orally-
administered to test for its platelet-increasing activity in thrombocytopenic Sprague-Dawley rats at doses
of 100-, 200-, 400-, 800- and 1600mg/kg. Thrombocytopenia was induced by orally administering
300mg/kg BW quinine sulfate for two days. Complete blood counts were done after the induction of
thrombocytopenia and after the treatment with the decoction for 2 weeks. Normal saline solution and
prednisolone were used as negative and positive controls, respectively.
One Way Analysis of Variance showed a significant increase in the number of platelets and WBC
between the groups given different doses of the extract against both positive and negative control groups.
(p<0.05). The number of RBC did not show any significant difference (p>0.05). This is furthermore
supported by data obtained from 95.0% Tukey’s HSD test. Values were outside the range limits for the
platelet and WBC while the values were all within range limits for the RBC.
The decoction of Ipomoea batatas possesses platelet-increasing activity. The increase in the number of
platelets was not consistent with the increments of dosage.